Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases

DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases

US Patent 10548900 · Granted Feb 4, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cellulose based anti-viral anti-microbial spray coating2025
Vesicular monoamine transporter-2 ligands and their use in the treatment of psyc2024
Tempo-cellulose structures and related methods2024
Tempo-cellulose structures and related methods2024
Compositions and methods for treatment of skin infections2023
Induced expression of brain derived neurotrophic factor (BDNF) for treatment of 2023
Induced expression of brain derived neurotrophic factor (BDNF) for treatment of 2023
Compositions and methods for treatment of skin infections2022
Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use the2022
Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use the2022
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, d2022
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, d2022